🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT07371598
Recruiting Not applicable

Royal Ancient Oats™ Study

NCT07371598 · tracked via the Priya Life Science USA tracker
Sponsor
Standard Process Inc.
Phase
Not applicable
Started
2026-01-13
Last updated
2026-01-28

Condition(s) studied

Healthy ParticipantsHealthy Glucose

Investigational drug(s) / intervention(s)

Royal Ancient Oat Flour™

Royal Ancient Oat Flour™: muffins made with Royal Ancient Oat Flour™

Study summary

Evaluating the effects of high avenanthramide ancient oat (Royal Ancient Oats™) muffins versus conventional oat muffins in regard to glycemic control.

Eligibility

Sex
ALL
Min age
35 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Non-diabetic (HbA1c\<5.7%) adults both men and women between the ages of 35-65 years with body mass index (BMI) ranging from 25 to 30 kg/m2 * Participants who meet the inclusion criteria will be screened prior to starting the study and must be able to adhere to the requirements of the study. * Willing to comply with study procedures and supplement regimens. * Providing consent to participate in the study. * Willing to limit/minimize foods that are rich sources of fiber and high carb content. * Participants should avoid taking any non-prescription/over-the-counter medications or nutritional supplements that could influence glycemic response. This includes vitamins, herbal supplements, and any medications affecting metabolism. Examples include probiotics and prebiotics, vit D, vit B12, Ginseng, fenugreek, weight loss supplements like green tea extract and Garcinia cambogia, fiber supplements like inulin and Psyllium husk. If participants need to make any changes due to health reasons, they should consult with the study coordinator before doing so. Exclusion Criteria: * Participants who have experienced weight loss or gain exceeding 5% of their body weight in the past 3 months, including those involved in any weight loss or weight gain programs through diet and/or lifestyle changes. * Participants currently taking medications that could alter metabolism, such as weight loss medications, anti-hypertensive drugs, or lipid-lowering medications. * Participants with any chronic metabolic diseases, including diabetes, or those using supplements other than a daily multivitamin. * Pregnant or lactating women will be excluded from the study. * Participants who use tobacco products. * Participants who are unwilling to limit or minimize foods that are rich sources of fiber and high carbohydrate content. * Excessive alcohol consumption (e.g., more than two drinks per day for men and more than one drink per day for women) * Inconsistency in recent or planned changes in non-prescription/over-the-counter medications or nutritional supplements affecting glycemic response, including vitamins (e.g., Vitamin D, Vitamin B12), herbal supplements (e.g., Ginseng, Fenugreek), weight loss supplements (e.g., green tea extract, Garcinia cambogia), fiber supplements (e.g., inulin, psyllium husk), and probiotics/prebiotics. * Inability or unwillingness to maintain the current regimen of these medications and supplements throughout the study period without consulting the study coordinator.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Standard Process Nutrition Innovation Center Kannapolis North Carolina Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07371598 on ClinicalTrials.gov ↗ ← All trials in the USA